Polar Asset Management Partners’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Polar Asset Management Partners’s Portfolio DMIIR Stock Details DMIIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	1,544,300 +44,300	+3%	+$3.79K	﹤0.01%	659
2026 Q1	$120K	Hold	1,500,000	–	–	﹤0.01%	505
2025 Q4	$210K	Buy	+1,500,000	New	+$214K	﹤0.01%	504

Other funds holding DMIIR

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Polar Asset Management Partners's DMIIR Position: Q2 2026 in Review

Polar Asset Management Partners increased its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 3% in Q2 2026, buying an estimated $3.79K and bringing the position to 1,544,300 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Polar Asset Management Partners first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. The position peaked at $210K in Q4 2025. 61 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

Polar Asset Management Partners held 1,544,300 shares of Drugs Made In America Acquisition II Corp Right worth $124K as of Q2 2026.
Polar Asset Management Partners bought 44,300 Drugs Made In America Acquisition II Corp Right shares in Q2 2026, an estimated $3.79K.
Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Polar Asset Management Partners's portfolio in Q2 2026, its #659 holding.
Polar Asset Management Partners first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
Polar Asset Management Partners's Drugs Made In America Acquisition II Corp Right position peaked at $210K in Q4 2025.
61 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on Polar Asset Management Partners's 13F filing for Q2 2026, filed 14 Aug 2026.